🇺🇸 FDA
Pipeline program

Dutasteride plus tamsulosin

116115

Approved small_molecule completed

Quick answer

Dutasteride plus tamsulosin for Prostatic Hyperplasia is a Approved program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline
Indication
Prostatic Hyperplasia
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials